@incollection{, 6D4A0919D168EC4614167BF43BC46DA3 , author={{Dr. GadangiIndira} and {Dr. GadangiIndira} and {Kakatiya University}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}1462326 } @incollection{b0, , title={{Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital}} , author={{ SIAnunnatsriri } and { PTowiwat } and { PChaimanee }} , journal={{Thailand. Southeast Asian J. Trop Med Public Health}} 43 5 , year={2012. Sep} } @incollection{b1, , title={{A multinational survey of risk factors for infection with extended-spectrum betalactamase producing Enterobacteriaceae in nonhospitalized patients}} , author={{ RBen-Ami }} , journal={{Clin. Infect. Dis}} 49 , year={2009} } @book{b2, , title={{Extendedspectrum-beta-lactamase production and fluoroquinolone resistance in pathogens associated with communityacquired urinary tract infection}} , author={{ MCormican } and { DMorris } and { GCorbett-Feeney } and { JFlynn }} } @incollection{b3, , title={{}} , journal={{DiagnMicrobiol Infect Dis}} 32 , year={1998} } @incollection{b4, , title={{Ebbing Lautenbach1, 2, Jean Baldus Patel3, Warren B}} , booktitle={{Extended-Spectrum ?-Lactamase}} 2 } @incollection{b5, , title={{}} , author={{ ProducingEscherichia } and { Klebsiellapneumoniae }} , journal={{Risk Factors for Infection and Impact of Resistance on OutcomesClin Infect Dis}} 32 8 , year={2001} } @incollection{b6, , title={{Epidemiology of urinary tract infections caused by extended-spectrumbeta-lactamase producing Escherichia coli}} , author={{ JEna } and { FArjona } and { CMartínez-Peinado }} , journal={{Urology}} 68 6 , year={2006} } @incollection{b7, , title={{Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli}} , author={{ CIKang }} , journal={{Int.J. Antimicrob. Agents}} 36 , year={2010} Cross ref Medline Google Schol } @incollection{b8, , title={{Communityacquired multiresistant bacteria: an emerging problem?}} , author={{ FXLescure } and { MEveillard } and { YDouadi } and { FEb }} , journal={{J Hosp Infect}} 49 , year={2001} } @incollection{b9, , title={{Nosocomial outbreak of Klebsiella infection resistant to thirdgeneration cephalosporins}} , author={{ KSMeyer } and { CUrban } and { JAEagan }} , journal={{Ann Intern Med}} 119 , year={1993} } @book{b10, , title={{Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard}} , year={1997} , address={Wayne, PA} National Committee for Clinical Laboratory Standards ; National Committee for Clinical Laboratory Standards , note={4th ed.. NCCLS document M7-A} } @incollection{b11, , title={{b-Lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates}} , author={{ SNijssen } and { AFlorijn } and { MJBonten }} , journal={{Int J Antimicrob Agents}} 2 , year={2004} } @incollection{b12, , title={{Analysis of 4,758 Escherichia colibacteraemia episodes: predictive factors for isolation of an antibioticresistant strain and their impact on the outcome}} , author={{ MOrtega } and { FMarco } and { ASoriano }} , journal={{J AntimicrobChemother}} 63 15 , year={2009} }